Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings. When not in office, Eliza enjoys reading, writing and learning new things about the world.

Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Dr. Tremblay specializes in hematologic malignancies including acute myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.